Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Marmara Pharmaceutical Journal
2016 , Vol 20 , Issue 2
Distribution of Sickle Cell Anemia in Turkey, Pathophysiology and Iron Toxicity
1Adli Bilimler Enstitüsü, Ankara Üniversitesi Tıp Fakültesi Cebeci Yerleşkesi, 06590, Dikimevi, Ankara
DOI :
10.12991/mpj.201620227342
Hemoglobinopathies is one of the most extensive single gene
disorders in the world and one of the most important type of
these diseases, sickle cell disease (SCD) is an autosomal recessive
inherited disorder of the red blood cells and affects many systems,
is seen frequently both for the our country and for Mediterranean
coastline region. The structure of the hemoglobin protein
in patients with SCD is different when compared to healthy
individuals. Patients with SCD have abnormal types of Hb, called
mutant Hemoglobin S (HbS) protein and this protein is able to
work as normal in an oxygenated environment. However, in an
oxygen poor environment this protein may cause the shape change in red blood cells. In other words they take the form of elongated
half moon or sickle shaped. The misshapen red cells can jam the
tiny vessels as a result, imparing circulation and slows or stops the
flow of blood. Vaso occlusive events result in tissue ischemia leading
to organ damage and loss of organ function. On the other hand,
repeated blood transfusions lead to iron overload in the tissues and
organs of these patients. Therefore organs affected and functions
are disrupted. Iron is a major component in the production and
metabolism of free radicals in biological systems. Last studies
indicate a significance of free radical mediated iron toxicity. In
conclusion, free iron plays a crucial role in oxidative stress. In
this review, detailed information about the pathophysiology, iron
toxicity and distribution of sickle cell anemia will be given in
Turkish population.
Keywords :
Sickle cell disease, Hemoglobin, Hemoglobin S, Iron; Iron toxicity